Temporarily switching from oral to intravenous selexipag in patients with pulmonary arterial hypertension: safety, tolerability, and pharmacokinetic results from an open-label, phase III study

Hans Klose, Kelly M. Chin, Ralf Ewert, Henning Gall, Joseph Parambil, David Poch, Hans Jürgen Seyfarth, Lene N. Axelsen, Shu Fang Hsu Schmitz, Claudia Stein, Ioana R. Preston